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LAS1-1 Potential of human organ generation in animals
Although it has been great hopes to apply the cells derived from human pluripotent stem cells (PSCs) for regenerative medicine, pharmacology, toxicity, however, realized examples are still remain a few. The major reason for this is that immature function of the differentiated cells and the huge cost to induce them. To solve this problem, our group proposes to use animals' developmental environment. When normal PSCs are transplanted and developed in an animal embryo genetically modified not to form target organ, the target organ of the chimeric animal should be derived from transplanted cells. Acutually, we showed that transplanted mouse pancreatic islet generated in apancreatic rat body could cure diabetic mice for a lifetime without rejection. This principle was also valid even in swine. However, there are many problems still remain to apply to humans. Biggest technical challenge is that there is no human PSCs capable to complement whole organ. Regulation issue is that Japanese guideline only allows 14 days culture in vitro for humananimal chimeric embryos and this is prominently restricted than the other countries. Establishment of human naive PSCs has a great interest in stem cell research field, and human-animal chimera formation is the key assay to prove their developmental potency. Thus, human-animal chimera is a critical study not only for practical research, but also for basic research. Since the guideline is under consideration, we hope it will be more useful for the most of researchers.
LAS1-2
Realizing for "Responsible Research and Innovation of Stem Cell Research"
○ Yoshimi Yashiro Center for iPS Cell Research and Application, Kyoto University
It is important that advanced science and t e c h n o l o g y , s u c h a s S t e m C e l l R e s e a r c h (SCR), is properly governed. Many factors need to be considered in order to ensure efficient governance, including social climate and public opinion. In a knowledge-based society, communication concerning science and technology is an important issue when it comes to establishing appropriate levels of trust between experts, the public, and other stakeholders.This way of thinking is called "responsible research and innovation (RRI)". RRI has been discussed and applied to science policy, particularly in the European framework Horizon 2020. regenerative medicine research enlarges the technically feasible areas, different beliefs about the knowledge of the research community and general public can become barriers to achieving broad acceptance of new innovative technologies that affect society. Considering the fact that SCR and Regenerative Medicine (RM) have opened up new dialogues with respect to basic research on, and clinical applications of, pluripotent stem cells, the lack of knowledge on current public attitudes towards iPSCs represents a serious problem. We therefore conducted a questionnaire to examine the attitudes of scientists and the public towards communication concerning SCR and RM. Our data indicate that an increased awareness of social responsibility and the regulatory framework is needed among scientists, in terms of the application of RM and its benefits as well as potential accidents, abuse, and other social consequences. Accordingly, training programs focusing on science policy and regulatory frameworks for scientists in the field of RM are essential.
LAS1-3
Future regulation for Animal-to-human chimeric embryos studies 
